Anti-Adhesion Products Market Size, Industry Analysis, Market trends, Cost and Forecasts to 2026

1
Anti-Adhesion Products Market To Reach USD 969.1
Million By 2026
www.reportsanddata.com
sales_at_reportsanddata.com
2
Market Summary
The rise in various disorders such as
cardiovascular, orthopedic and target disorders
which can be treated only through surgical
methods, rising awareness in developing
economies, ageing population, rising cases of
abdominal surgeries are key factors contributing
to high CAGR of Anti-adhesion market during the
forecast period. Market Size USD 550.8 Million
in 2018, Market Growth - CAGR of 7.2, Market
Trends soaring number of surgeries worldwide,
Rapid Rise in Cardiovascular Surgical Procedures
Confers Opportunity for Anti-Adhesion Products
Adoption
3
Our Approach
Market Summary

• According to the current analysis of Reports and
  Data, the global anti-adhesion products market
  was valued at USD 550.8 million in 2018 and is
  expected to reach USD 969.1 million by the year
  2026, at a CAGR of 7.2. Adhesions are bands of
  sticky tissues that adhere to the surfaces of
  internal organs and tissues together, obstructing
  the area of its formation. This process happens
  post surgeries relating to gynecology,
  cardiovascular, orthopedic, abdominal surgery,
  and other surgeries. Approximately 10 million
  people have osteoporosis, and 44 million suffer
  from low bone density in America according to the
  national osteoporosis foundation. The formation
  of adhesions is originally a natural healing
  process of the body wherein the body recovers
  itself from the trauma of surgery or any other
  massive wounds caused due to an accident. The
  anti-adhesion products are used to treat these
  adhesions, as any drug therapy cannot handle
  them.
• The anti-adhesion products market is widely
  driven by the rising number of surgeries among
  the global population, mainly due to lifestyle
  disorders. According to the American Heart
  Association, 121.5 million Americans have one or
  more types of cardiovascular disease in the US.
  Adhesions frequently occur after abdominal
  surgery. Postoperative adhesions, which could
  cause chronic pelvic pain, intestinal
  obstruction, and infertility, often occur after
  abdominal surgery. Several products, in the form
  of film or fluid, are widely used to prevent
  postoperative adhesion formation.
• Key participants include Johnson Johnson,
  Sanofi S.A. , Baxter International, Inc., Becton
  Dickinson and Company, Anika Therapeutics Inc,
  Ethicon US LLC, FzioMed, Inc., Integra
  LifeSciences Corporation, MAST Biosurgery ,
  Terumo Corporation and BMI Korea Co.
• To Get Sample Copy of Report visit
  https//www.reportsanddata.com/sample-enquiry-form
  /2470

4
Our Approach
Market Summary

• Product Outlook (Revenue in Million USD
  20162026)
• Synthetic Adhesion
•  Polyethylene Glycol
• Hyaluronic Acid
• Regenerated Cellulose
• Natural Adhesion Barriers
• Collagen Protein
• Fibrin
• Application Outlook (Revenue in Million USD
  20162026)
• Cardiovascular surgery
• Orthopedic surgery
• Gynecological surgery
• General/ abdominal Surgery
• Neurological surgery
• Urological Surgery
• Others

5
Our Approach
Market Summary

• Formulation Outlook (Revenue in Million USD
  20162026)
• Gels
• Films
• Liquid
• End-use Outlook (Revenue in Million USD
  20162026)
• Hospitals
• Clinics
• Ambulatory surgery centers
• Others
• Do you have questions about the Report or want to
  inquire about a Discount? Ask our Expert
  https//www.reportsanddata.com/discount-enquiry-fo
  rm/2470

6
Our Approach
Market Summary

• Further key findings from the report suggest
• Pelvic surgery often causes unavoidable tissue
  injury and that can lead to the formation of
  post- surgical adhesion owning to the rising
  demand for anti-adhesion products.The
  polyethylene glycol segment is expected to grow
  with a CAGR of 7.6 during the forecast period
  owing to its high efficacy and better results.
• According to European Society for Gynaecological
  Endoscopy (ESGE) more than 50 respondents
  provided results to a survey in U.K. that
  adhesions are a most common complication post
  surgeries. Therefore, this region is driving
  factor for the market growth.
• The target diseases such as cancer, pelvic
  surgeries and C-sections have significantly
  increased in number owing to the rising demand
  for anti-adhesion products.ïAccording to the
  National Cancer Institute in 2018, the most
  common cancers are breast cancer, lung and
  bronchus cancer, prostate cancer, colon and
  rectum cancer, melanoma of the skin, bladder
  cancer, non-Hodgkin lymphoma, kidney and renal
  pelvis cancer, endometrial cancer. to a boost to
  the anti-adhesion product market.
• Many companies had to face a lot of difficulties
  for approval of these anti-adhesion products due
  to questions on their clinical efficacy and
  safety. Recently, in December 2019 Baxter
  International entered into an agreement with
  Sanofi and picked up Seprafilm an anti-adhesion
  product for USD 350 million. Seprafilm is a US
  FDA approved product and is extensively used as
  anti-adhesion product. This acquisition has
  helped Baxter to increase their product line in
  the market.
• Read More _at_ https//www.reportsanddata.com/report-
  detail/anti-adhesion-products-market

7
Our Approach
About Us

• Reports and Data is a market research and
  consulting company that provides syndicated
  research reports, customized research reports,
  and consulting services. Our solutions purely
  focus on your purpose to locate, target and
  analyze consumer behavior shifts across
  demographics, across industries and help clients
  make a smarter business decision. We offer market
  intelligence studies ensuring relevant and
  fact-based research across a multiple industries
  including Healthcare, Technology, Chemicals,
  Power, and Energy. We consistently update our
  research offerings to ensure our clients are
  aware about the latest trends existent in the
  market. Reports and Data has a strong base of
  experienced analysts from varied areas of
  expertise.
• Contact Us
• John Watson
• Head of Business Development
• Reports And Data Web www.reportsanddata.com
• Direct Line 1-212-710-1370
• E-mail sales_at_reportsanddata.com